By Counterforce Health Team in Photrexa (riboflavin ophthalmic solution) —

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by Aetna CVS Health in Florida

Photrexa (riboflavin ophthalmic solution) requires prior authorization from Aetna CVS Health in Florida. Submit PA request through Availity provider portal with: keratoconus progression documentation (Kmax values), failed conservative treatments, FDA-approved iLink system confirmation. Standard decision: 30-45 days. If denied, file internal appeal within 180 days, then external review via Florida Department of Financial Services within 4 months. Florida law prohibits "fail twice" step therapy—physician medical necessity notice can override requirements.

Start today: Contact your ophthalmologist to gather corneal topography showing progression and request PA submission.

Table of Contents

Why Florida State Rules Matter

Florida's insurance regulations provide specific protections that can help you get Photrexa covered, even when Aetna CVS Health initially denies coverage. Understanding these state-level protections helps you navigate the prior authorization process more effectively.

Key Florida advantages:

  • No "fail twice" step therapy requirements for prescription drugs
  • 180-day appeal deadline (longer than some states)
  • Free external review through independent medical experts
  • Strong continuity of care protections for ongoing specialty treatments
From our advocates: We've seen Florida patients successfully overturn Photrexa denials by citing the state's step therapy protections. One patient's ophthalmologist submitted a medical necessity notice showing that rigid contact lenses (the typical first-line treatment) weren't FDA-approved for halting keratoconus progression—only for vision correction. This medical exception helped bypass Aetna's step therapy requirements entirely.

Aetna CVS Health Prior Authorization Requirements

Coverage at a Glance

Requirement What It Means Where to Find It Timeline
Prior Authorization Required before treatment Aetna Provider Portal 30-45 days standard
Medical Necessity Must prove progression Ophthalmologist documentation Submit with PA
iLink System FDA-approved device required Facility confirmation Verify before scheduling
Step Therapy May require failed alternatives Florida override available 30+ days notice

Step-by-Step: Fastest Path to Approval

  1. Gather progression documentation (Patient + Ophthalmologist)
    • Serial corneal topography showing Kmax increase ≥1.0D
    • Visual acuity decline records
    • Failed conservative treatment notes (contact lenses, glasses)
  2. Verify facility and device (Ophthalmologist)
    • Confirm iLink system availability at treatment center
    • Obtain NDC/J-code for Photrexa from facility
    • Document epithelium-off protocol compliance
  3. Submit PA request (Ophthalmologist/Staff)
    • Use Availity provider portal (preferred method)
    • Include medical necessity letter citing FDA indication
    • Attach all supporting documentation
  4. Track submission (Patient + Ophthalmologist)
    • Monitor via Availity or call Aetna provider line
    • Standard decision timeline: 30-45 days
    • Expedited available if vision deterioration threatens harm
  5. Prepare for potential denial (Patient)
    • Understand common denial reasons (see table below)
    • Gather additional evidence if needed
    • Know your appeal rights and deadlines

Common Denial Reasons & Fixes

Denial Reason How to Overturn Required Documents
"Experimental/Investigational" Cite FDA approval (2016) FDA labeling, AAO guidelines
Missing progression evidence Submit serial topography Kmax values with dates
Step therapy not completed File medical necessity exception Physician override notice
Out-of-network facility Request network adequacy review Geographic access documentation
Non-formulary drug Request formulary exception Medical necessity letter

Step Therapy Protections in Florida

Florida law provides strong protections against excessive step therapy requirements. Insurers cannot require failure of two prior therapies before approving a requested drug.

Medical Exception Process

Your ophthalmologist can override step therapy by submitting a notice of medical necessity that includes:

  • Certification that Photrexa is medically necessary based on clinical judgment
  • Documentation that step therapy drugs aren't FDA-approved for keratoconus progression (only vision correction)
  • Evidence that delay could worsen corneal thinning or visual outcomes

Timeline: Submit at least 30 days before any formulary change. Aetna must authorize coverage without imposing new restrictions.

Clinician Corner: When drafting medical necessity letters for Photrexa, emphasize that keratoconus is a progressive disease where timing matters. Include specific Kmax progression values, document failed conservative treatments, and cite the FDA indication for "progressive keratoconus and corneal ectasia." Reference American Academy of Ophthalmology guidelines supporting corneal cross-linking for documented progression.

Appeals Process: Internal and External Review

Internal Appeals with Aetna CVS Health

Filing deadline: 180 calendar days from denial notice Decision timeline: 30 days (pre-service), 60 days (post-service), 72 hours (expedited)

How to file:

  1. Use Availity provider portal (mark "EXPEDITED" if urgent)
  2. Include original denial letter and all supporting documentation
  3. Submit additional evidence: peer-reviewed studies, progression photos, specialist letters

Required documents:

  • Complete denial letter from Aetna
  • Medical records showing keratoconus progression
  • Prior treatment failures documentation
  • Ophthalmologist's medical necessity letter
  • FDA labeling for Photrexa

External Review Through Florida DFS

If Aetna denies your internal appeal, you can request an independent external review through the Florida Department of Financial Services.

Eligibility requirements:

  • Exhausted Aetna's internal appeal process
  • Disputed amount exceeds $500
  • Request filed within 4 months of final internal denial

How to request:

  1. Call Florida Insurance Helpline: 1-877-693-5236
  2. Request external review form and instructions
  3. Submit completed form with all denial letters and medical records

Timeline:

  • Standard review: 45 days
  • Expedited (urgent cases): 72 hours
  • Decision is binding on Aetna if approved
  • No cost to you

The independent review organization will assign a board-certified ophthalmologist to review your case using evidence-based criteria and medical necessity standards.

Continuity of Care Protections

If you're changing insurance plans or your ophthalmologist leaves Aetna's network during ongoing keratoconus treatment, Florida provides continuity of care protections.

For Medicaid members: Up to 60 days of continued coverage for previously authorized services without new prior authorization requirements.

For commercial members: HMO contracts must provide notice before provider termination and allow policyholders to continue coverage for a specified timeframe.

Actionable steps:

  1. Document all prior authorizations and treatment plans
  2. Notify new insurer immediately about ongoing keratoconus treatment
  3. Request continuity of care review for specialty ophthalmology services
  4. File complaints with Florida Department of Financial Services if denied

When to File a State Complaint

The Florida Division of Consumer Services handles insurance complaints when Aetna fails to follow proper procedures or delays decisions unreasonably.

File a complaint if:

  • PA decision exceeds 45-day timeline without explanation
  • Appeal response is delayed beyond required timeframes
  • Aetna fails to provide required denial reasons or appeal instructions
  • Step therapy requirements violate Florida law

How to file:

  1. Visit MyFloridaCFO.com > Consumer Services > File Insurance Complaint
  2. Provide policy number, claim details, and timeline of communications
  3. Upload all relevant documents
  4. DFS will contact Aetna within 30 days and track resolution

Practical Scripts and Templates

Patient Phone Script for Aetna

"Hi, I'm calling about prior authorization for Photrexa riboflavin for progressive keratoconus. My member ID is [NUMBER]. My ophthalmologist submitted the PA request on [DATE] through Availity. Can you confirm receipt and provide the current status? If there are any missing documents, please specify exactly what's needed so we can expedite the review."

Medical Necessity Letter Template Points

Your ophthalmologist should include:

  • Patient diagnosis: Progressive keratoconus (ICD-10: H18.621)
  • Documented progression: Kmax increase from [VALUE] to [VALUE] over [TIMEFRAME]
  • Failed conservative treatments: Contact lens intolerance, inadequate vision correction
  • FDA indication: Photrexa with iLink for epithelium-off corneal cross-linking
  • Clinical urgency: Progressive corneal thinning requires intervention to prevent further deterioration

Cost Savings and Patient Assistance

Manufacturer support: Contact Glaukos (verify current patient assistance programs)

Procedure costs: Typically $2,500-$4,000 per eye for the complete treatment (drug + device + facility)

Coverage trends: Increasing approval rates for epithelium-off cross-linking as evidence base grows

Financial assistance options:

  • Check eligibility for Medicaid or marketplace subsidies
  • Inquire about facility payment plans
  • Research vision-specific foundations and grants

When navigating insurance coverage challenges, Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters and plan policies to craft point-by-point rebuttals aligned with payer requirements, pulling the right clinical evidence and procedural details that improve approval rates.

FAQ: Common Questions

How long does Aetna CVS Health prior authorization take in Florida? Standard decisions take 30-45 days. Expedited reviews (when delay threatens health) are decided within 72 hours. Track status through the Availity provider portal.

What if Photrexa is non-formulary on my plan? Request a formulary exception with medical necessity documentation. Your ophthalmologist must demonstrate that formulary alternatives aren't appropriate for progressive keratoconus treatment.

Can I request an expedited appeal if my keratoconus is worsening? Yes. If delay in treatment could cause serious deterioration in vision or corneal stability, mark your appeal "EXPEDITED." Your ophthalmologist must certify the urgency.

Does step therapy apply if I tried treatments outside Florida? Yes, but Florida law allows medical necessity exceptions. Your ophthalmologist can override step therapy requirements by certifying that Photrexa is medically necessary based on clinical judgment.

What happens if Aetna denies my external review? External review decisions are binding on Aetna if they approve coverage. If the external reviewer upholds the denial, you may have limited additional options, but consult with your ophthalmologist about alternative treatments or appeals to other aspects of the denial.

How do I find an in-network facility with the iLink system? Use Aetna's provider directory to search for ophthalmology practices, then call directly to confirm iLink availability. The device is required for FDA-approved Photrexa treatment.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations may change. Always verify current requirements with your insurer and consult your healthcare provider for medical decisions.

For additional assistance with insurance appeals and coverage challenges, Counterforce Health provides specialized support for patients and providers navigating complex prior authorization and appeals processes.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.